Search Results

By Syed A. Abutalib, MD and Alex Francisco Herrera, MD  / April 25, 2024

Advanced-Stage Classical Hodgkin Lymphoma

Classical Hodgkin lymphoma (HL) is a highly curable disease, but up to 25% of patients will develop relapsed or refractory classical HL. Although most patients achieve complete response following front-line therapy, key unmet clinical needs include reducing the relapse rate, decreasing acute and...